The DOI matches its Crossref record; 103 of the 103 references it cites were found in a registry or an index.
Efficacy of Drug Treatment in Obsessive–Compulsive Disorder: a Meta-Analytic Review
Abstract
Background: A review of the efficacy of antidepressant drug treatment in patients with obsessive–compulsive disorder (OCD), using a meta-analytic approach. Method: Randomised double-blind clinical trials of antidepressant drugs, carried out among patients with OCD and published in peer-reviewed journals between 1975 and May 1994, were selected together with three studies currently in press. Forty-seven trials were located by searching the Medline and Excerpta Medica – Psychiatry data bases, scanning psychiatric and psychopharmacological journals, consulting recent published reviews and bibliographies, contacting pharmaceutical companies and through cross-references. Hedges'g was computed in pooled data at the conclusion of treatment under double-blind conditions or at the latest reported point of time during this treatment period. For each trial, effect sizes were computed for all available outcome measures of the following dependent variables: obsessive–compulsive symptoms considered together; obsessions; compulsions; depression; anxiety; global clinical improvement; psychosocial adjustment; and physical symptoms. Results: Clomipramine was superior to placebo in reducing both obsessive–compulsive symptoms considered together (g= 1.31; 95% CI = 1.15 to 1.47) as well as obsessions (g= 0.89, 95% CI = 0.36 to 1.42) and compulsions (g= 0.79; 95% CI = 0.34 to 1.24) taken separately. Also, selective serotonin re-uptake inhibitors (SSRIs) as a class were superior to placebo, weighted mean g being respectively 0.47 (95% CI = 0.33 to 0.61), 0.54 (95% CI = 0.34 to 0.74) and 0.52 (95% CI = 0.34 to 0.70) for obsessive–compulsive symptoms considered together, and obsessions and compulsions taken separately. Although on Y–BOCS the increase in improvement rate over placebo was 61.3%, 28.5%, 28.2% and 21.6% for clomipramine, fluoxetine, fluvoxamine, and sertraline respectively, the trials testing clomipramine against fluoxetine and fluvoxamine showed similar therapeutic efficacy between these drugs. Finally, both clomipramine and fluvoxamine proved superior to antidepressant drugs with no selective serotonergic properties. Conclusion: Antidepressant drugs are effective in the short-term treatment of patients suffering from OCD; although the increase in improvement rate over placebo was greater for clomipramine than for SSRIs, direct comparison between these drugs showed that they had similar therapeutic efficacy on obsessive–compulsive symptoms; clomipramine and fluvoxamine had greater therapeutic efficacy than antidepressant drugs with no selective serotonergic properties; concomitant high levels of depression at the outset did not seem necessary for clomipramine and for SSRIs to improve obsessive–compulsive symptoms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
Statistical Aspects of the Analysis of Data From Retrospective Studies of Disease
(1959) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/22.4.719 · Cited by 14,689
The file drawer problem and tolerance for null results.
Rosenthal, R. (1979) · Psychological Bulletin · doi:10.1037/0033-2909.86.3.638 · Cited by 9,068
The Yale-Brown Obsessive Compulsive Scale: I. Development, Use, and Reliability
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110048007 · Cited by 7,712
Distribution Theory for Glass's Estimator of Effect Size and Related Estimators
Hedges, L. V. (1981) · Journal of Educational Statistics · doi:10.2307/1164588 · Cited by 5,695
Meta-Analytic Procedures for Social Research.
Metcalfe, A., & Rosenthal, R. (1994) · The Statistician · doi:10.2307/2348600 · Cited by 4,249
The Yale-Brown Obsessive Compulsive Scale: II. Validity
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110054008 · Cited by 2,799
Psychiatric disorders in America: the epidemiologic catchment area study
(1991) · Choice Reviews Online · doi:10.5860/choice.28-5931 · Cited by 2,555
Lifetime Prevalence of Specific Psychiatric Disorders in Three Sites
Robins, L. N. (1984) · Archives of General Psychiatry · doi:10.1001/archpsyc.1984.01790210031005 · Cited by 2,550
Meta-analysis of psychotherapy outcome studies.
Smith, M. L., & Glass, G. V. (1977) · American Psychologist · doi:10.1037/0003-066x.32.9.752 · Cited by 2,154
Smith, M. L., Glass, G. V., & Miller, T. I. (1980) · Medical Entomology and Zoology · Cited by 2,123
Psychiatric disorders in America
Robins, L. N. (1991) · Medical Entomology and Zoology · Cited by 1,567
Statistical Methods in Medical Research.
Wickham, C. A. C., Armitage, P., & Berry, G. (1988) · Journal of the Royal Statistical Society. Series A (Statistics in Society) · doi:10.2307/2982765 · Cited by 1,397
Methods for combining randomized clinical trials: Strengths and limitations
Demets, D. L. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060325 · Cited by 1,027
Marks, I. M. (1987) · Cited by 978
Clomipramine Treatment of Obsessive-Compulsive Disorder: I. A Controlled Clinical Trial
Thorén, P. (1980) · Archives of General Psychiatry · doi:10.1001/archpsyc.1980.01780240079009 · Cited by 497
The Epidemiology and Differential Diagnosis of Obsessive-Compulsive Disorder
Rasmussen, S. A., & Eisen, J. L. (1992) · Zwangsstörungen / Obsessive-Compulsive Disorders · doi:10.1007/978-3-642-77608-3_1 · Cited by 493
Clomipramine Treatment of Childhood Obsessive-Compulsive Disorder: A Double-blind Controlled Study
Flament, M. F. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790330057007 · Cited by 466
Clomipramine and Exposure for Obsessive-Compulsive Rituals: 1
Marks, I. M., Stern, R. S., Mawson, D., Cobb, J., & McDonald, R. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.1.1 · Cited by 448
Regier, D. A., Farmer, M. E., Rae, D. S., Myers, J. K., Kramer, M., Robins, L. N., George, L. K., Karno, M., & Locke, B. Z. (1993) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1993.tb03411.x · Cited by 437
Zohar, J., & Insel, T. R. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90199-5 · Cited by 416
Comparing effect sizes of independent studies.
Rosenthal, R., & Rubin, D. B. (1982) · Psychological Bulletin · doi:10.1037//0033-2909.92.2.500 · Cited by 406
A 2- to 7-Year Follow-up Study of 54 Obsessive-Compulsive Children and Adolescents
Leonard, H. L. (1993) · Archives of General Psychiatry · doi:10.1001/archpsyc.1993.01820180023003 · Cited by 401
Selective serotonin reuptake inhibitors: meta-analysis of efficacy and acceptability.
Song, F., Freemantle, N., Sheldon, T. A., House, A., Watson, P., Long, A., & Mason, J. (1993) · BMJ · doi:10.1136/bmj.306.6879.683 · Cited by 399
Efficacy of Fluvoxamine in Obsessive-Compulsive Disorder: A Double-blind Comparison With Placebo
Goodman, W. K. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810010038006 · Cited by 390
Clomipramine in the Treatment of Patients With Obsessive-Compulsive Disorder
(1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810320054008 · Cited by 388
Leonard, H. L. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810120030006 · Cited by 369
DEVEAUGH-GEISS, J., MOROZ, G., BIEDERMAN, J., CANTWELL, D., FONTAINE, R., GREIST, J. H., REICHLER, R., KATZ, R., & LANDAU, P. (1992) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199201000-00008 · Cited by 349
Obsessive-compulsive disorder and serotonin: Is there a connection?
Insel, T. R., Mueller, E. A., Alterman, I., Linnoila, M., & Murphy, D. L. (1985) · Biological Psychiatry · doi:10.1016/0006-3223(85)90176-3 · Cited by 343
Obsessive-Compulsive Disorder: A Double-blind Trial of Clomipramine and Clorgyline
Insel, T. R. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.04390010015002 · Cited by 343
Goodman, W. K. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810180077011 · Cited by 311
Hudak, R., & Gannon, J. M. (2022) · Current Clinical Practice · doi:10.1007/978-3-030-98709-1_5 · Cited by 306
An analysis of psychotherapy versus placebo studies
Prioleau, L., Murdock, M., & Brody, N. (1983) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00015867 · Cited by 261
Clomipramine, self-exposure and therapist-aided exposure for obsessive–compulsive rituals
Marks, I. M., Lelliott, P., Basoglu, M., Noshirvani, H., Monteiro, W., Cohen, D., & Kasvikis, Y. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.152.4.522 · Cited by 255
Chalmers, T. C., Levin, H., Sacks, H. S., Reitman, D., Berrier, J., & Nagalingam, R. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060320 · Cited by 246
Swan, G. E. (1984) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(84)90040-5 · Cited by 243
Pigott, T. A. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810220042005 · Cited by 221
Confronting publication bias: A cohort design for meta‐analysis
Simes, R. J. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060104 · Cited by 216
Fluvoxamine treatment of obsessive-compulsive disorder
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.12.1543 · Cited by 214
A Controlled Study of Fluvoxamine and Exposure in Obsessive-Compulsive Disorder
COTTRAUX, J., MOLLARD, E., BOUVARD, M., MARKS, I., SLUYS, M., NURY, A. M., DOUGE, R., & CIALDELLA, P. (1990) · International Clinical Psychopharmacology · doi:10.1097/00004850-199001000-00002 · Cited by 203
Foa, E. B., & Emmelkamp, P. M. G. (1983) · UvA-DARE (University of Amsterdam) · Cited by 203
Collins, R., Gray, R., Godwin, J., & Peto, R. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060308 · Cited by 178
Montgomery, S. (1993) · European Neuropsychopharmacology · doi:10.1016/0924-977x(93)90266-o · Cited by 172
Schizophrenia-like psychoses associated with organic cerebral disorders: a review.
Davison, K. (1983) · PubMed · Cited by 170
Perusing the literature: Comparison of MEDLINE searching with a perinatal trials database
Dickersin, K., Hewitt, P., Mutch, L., Chalmers, I., & Chalmers, T. C. (1985) · Controlled Clinical Trials · doi:10.1016/0197-2456(85)90106-0 · Cited by 167
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.9.1209 · Cited by 164
DEN BOER, J. A., WESTENBERG, H. G. M., KAMERBEEK, W. D. J., VERHOEVEN, W. M. A., & KAHN, R. S. (1987) · International Clinical Psychopharmacology · doi:10.1097/00004850-198701000-00002 · Cited by 160
Christensen, H. M., Hadži-Pavlović, D., Andrews, G., & Mattick, R. P. (1987) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.55.5.701 · Cited by 150
Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis
Ananth, J., Pecknold, J. C., Steen, N. V. D., & Engelsmann, F. F. (1981) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(81)90077-1 · Cited by 150
Chouinard, G., Goodman, W. K., Greist, J. H., Jenike, M. A., Rasmussen, S., White, K., Hackett, E., Gaffney, M., & Bick, P. A. (1990) · PubMed · Cited by 136
Clomipramine, Clonazepam, and Clonidine Treatment of Obsessive-Compulsive Disorder
HEWLETT, W. A., VINOGRADOV, S., & AGRAS, W. S. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199212000-00008 · Cited by 129
Lithium Prophylaxis in Recurrent Affective Illness: Efficacy, Effectiveness and Efficiency
Guscott, R. G., & Taylor, L. K. (1994) · The British Journal of Psychiatry · doi:10.1192/bjp.164.6.741 · Cited by 129
Clomipramine and imipramine in obsessive-compulsive disorder
Volavka, J., Neziroglu, F. A., & Yaryura-Tobias, J. A. (1985) · Psychiatry Research · doi:10.1016/0165-1781(85)90092-7 · Cited by 124
Pharmacotherapy of Obsessive-Compulsive Disorder
Goodman, W. K. (1992) · Springer eBooks · doi:10.1007/978-3-642-77608-3_13 · Cited by 118
Mavissakalian, M., Turner, S. M., Michelson, L. K., & Jacob, R. G. (1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.5.572 · Cited by 115
Meta-analysis: Techniques, applications, and functions.
Strube, M., & Hartmann, D. P. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.51.1.14 · Cited by 113
Controlled comparison of buspirone and clomipramine in obsessive- compulsive disorder
Pato, M. T., Pigott, T. A., Hill, J., Grover, G. N., Bernstein, S., & Murphy, D. L. (1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.1.127 · Cited by 107
KAHN, R. S., Westenberg, H. G. M., Verhoeven, W. M. A., Wied, C. C. G., & KAMERBEEK, W. D. J. (1987) · International Clinical Psychopharmacology · doi:10.1097/00004850-198701000-00003 · Cited by 106
Jp, Z., Miller, J. J., Sheehan, D. V., & Bs, F. (1988) · PubMed · Cited by 101
A measure to aid in the interpretation of published clinical trials
Begg, C. B. (1985) · Statistics in Medicine · doi:10.1002/sim.4780040103 · Cited by 100
Biological Approaches to Treatment-Resistant Obsessive-Compulsive Disorder
Goodman, W. K., Rudorfer, M. V., & Maser, J. D. (2017) · Routledge eBooks · doi:10.4324/9781315561073-31 · Cited by 97
Cottraux, J. A., Mollard, E., Bouvard, M. A., & Marks, I. M. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90030-k · Cited by 96
Leonard, H., Swedo, S. E., Rapoport, J. L., Coffey, M., & Cheslow, D. L. (1988) · PubMed · Cited by 94
Clomipramine in Obsessive-Compulsive Disorder
MAVISSAKALIAN, M. R., JONES, B., Olson, S., & Perel, J. M. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199008000-00005 · Cited by 92
Senn, S. J., & Brand, R. (1994) · Statistics in Medicine · doi:10.1002/sim.4780130310 · Cited by 91
Mawson, D. C., Marks, I. M., & Ramm, L. (1982) · The British Journal of Psychiatry · doi:10.1192/bjp.140.1.11 · Cited by 90
Specialist mental health treatment in general practice: a meta-analysis
Balestrieri, M., Williams, P. R., & Wilkinson, G. (1988) · Psychological Medicine · doi:10.1017/s0033291700008400 · Cited by 88
Self-citationAre there Anticompulsive or Antiphobic Drugs? Review of the Evidence
Marks, I. M. (1983) · The British Journal of Psychiatry · doi:10.1192/bjp.143.4.338 · Cited by 81
Jenike, M. A., Baer, L., D, P. S. M., Weilburg, J. B., Holland, A. J., & Seymour, R. (1989) · American Journal of Psychiatry · doi:10.1176/ajp.146.10.1328 · Cited by 79
Clomipramine versus Phenelzine in Obsessive–Compulsive Disorder: A Controlled Clinical Trial
Vallejo, J., Olivares, J., Marcos, T., Bulbena, A., & Menchón, J. M. (1992) · The British Journal of Psychiatry · doi:10.1192/bjp.161.5.665 · Cited by 78
Jenike, M. A., Baer, L., & Greist, J. H. (1990) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199004000-00008 · Cited by 75
The Behavior of Psychiatric Patients: Quantitative Techniques for Evaluation
Kimball, C. P., & Moulthrop, M. A. (1984) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198408000-00014 · Cited by 75
Obsessive-compulsive disorder: a treatment review.
Perse, T. (1988) · PubMed · Cited by 74
Current issues in the pharmacologic management of obsessive compulsive disorder.
Rasmussen, S. A., Eisen, J. L., & Pato, M. T. (1993) · PubMed · Cited by 74
Jenike, M. A., Baer, L., D, P. S. M., Minichiello, W. E., Holland, A. J., & Seymour, R. (1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.7.923 · Cited by 73
Preliminary results from a multicenter trial of clomipramine in obsessive-compulsive disorder.
DeVeaugh-Geiss, J., Landau, P., & Katz, R. (1989) · PubMed · Cited by 68
Directory of registries of clinical trials
Easterbrook, P. (1992) · Statistics in Medicine · doi:10.1002/sim.4780110307 · Cited by 65
Brand, R., & Kragt, H. (1992) · Statistics in Medicine · doi:10.1002/sim.4780111605 · Cited by 64
A Double-Blind, Placebo Controlled Study of Trazodone
Pigott, T. A., L'Heureux, F., Rubenstein, C., BERNSTEIN, S. E., Hill, J., & Murphy, D. L. (1992) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-199206000-00002 · Cited by 63
Wilkinson, G., Balestrieri, M., Ruggeri, M., & Bellantuono, C. (1991) · Psychological Medicine · doi:10.1017/s0033291700029986 · Cited by 63
Self-citationClinical controlled trial of chlorimipramine in adolescents with obsessive-compulsive disorder.
Rapoport, J., Elkins, R., & Mikkelsen, E. J. (1980) · PubMed · Cited by 61
Directory of registries of clinical trials.
Easterbrook, P. (1992) · PubMed · Cited by 60
Greist, J. H., Jefferson, J. W., Rosenfeld, R., Gutzmann, L. D., March, J. S., & Barklage, N. E. (1990) · PubMed · Cited by 58
Sertraline in the Treatment of Obsessive Compulsive Disorder
Chouinard, G. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199210002-00007 · Cited by 55
Meta-analytic procedures for social research
Gröndal, G. W. (1993) · Evaluation Practice · doi:10.1016/0886-1633(93)90018-k · Cited by 55
Obtaining medically meaningful answers from an overview of randomized clinical trials
Yusuf, S. (1987) · Statistics in Medicine · doi:10.1002/sim.4780060314 · Cited by 54
Tricyclic Antidepressants in Obsessive-Compulsive Disorder Antiobsessional or Antidepressant Agents?
MAVISSAKALIAN, M. R., & Michelson, L. K. (1983) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-198305000-00007 · Cited by 50
The meta-analytic revolution in outcome research.
Fiske, D. W. (1983) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.51.1.65 · Cited by 49
A Double Blind Study of Imipramine versus Zimelidine in Treatment of Obsessive Compulsive Neurosis
Prasad, A. (1984) · Pharmacopsychiatry · doi:10.1055/s-2007-1017409 · Cited by 42
Short- and Long-Term Treatment of Obsessive-Compulsive Disorder with Fluvoxamine
Mallya, G. K., White, K., WATERNAUX, C. M., & Quay, S. (1992) · Annals of Clinical Psychiatry · doi:10.3109/10401239209150443 · Cited by 41
Ondansetron, a 5-HT3 receptor antagonist, partially attenuates the effects of amphetamine
Silverstone, P. H., Oldman, D., Johnson, B., & Cowen, P. J. (1992) · International Clinical Psychopharmacology · doi:10.1097/00004850-199200710-00005 · Cited by 40
Pharmacotherapy of obsessive compulsive disorder-experience with fluoxetine
Wood, A., Tollefson, G. D., & Birkett, M. A. (1993) · International Clinical Psychopharmacology · doi:10.1097/00004850-199300840-00015 · Cited by 33
Double-blind controlled study in phobias and obsessions.
Karabanow, O. (1977) · PubMed · Cited by 32
Foa, E. B., Steketee, G. S., Kozak, M. J., & Dugger, D. (1987) · PubMed · Cited by 30
Biological Approaches to Treatment-Resistant Obsessive-Compulsive Disorder
Goodman, W. K., Ward, H. E., Kablinger, A. S., & Murphy, T. K. (1999) · Routledge eBooks · doi:10.4324/9781410603241-23 · Cited by 29
Hoehn-Saric, R., McLeod, D. R., Zimmerli, W. D., & Hipsley, P. A. (1993) · PubMed · Cited by 22
Pharmacotherapy of Obsessive‐Compulsive Disorder
Jermain, D. M., & Crismon, M. L. (1990) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1990.tb02574.x · Cited by 21
Clomipramine (Anafranil) and behaviour therapy in obsessive-compulsive and phobic disorders.
Mm, A., Ban, T. A., Pecknold, J. C., & Klingner, A. (1977) · PubMed · Cited by 18
Cassano, G. B., Castrogiovanni, P., Mauri, M., et al. (1981) · Progress in Neuro-Psychopharmacology · doi:10.1016/0364-7722(81)90061-8 · Cited by 15
Serotonin and treatment in obsessive-compulsive disorder.
Js, M., Gutzmann, L. D., Jw, J., & Greist, J. H. (1989) · PubMed · Cited by 12
Are there anticompulsive or antiphobic drugs? Review of the evidence.
MARKS, I. (1982) · PubMed · Cited by 12
The boy who couldn’t stop washing
Rolls, G. (2019) · Routledge eBooks · doi:10.4324/9780429294754-20 · Cited by 11
Double-blind comparison of fluoxetine and clomipramine in obsessive-compulsive disorder
Saíz, J., López-Ibor, J. J., Cottreaux, J., et al. (1991) · European Neuropsychopharmacology · doi:10.1016/0924-977x(91)90706-z · Cited by 9
Cited by
Katzman, M. A., Bleau, P., Blier, P., Chokka, P., Kjernisted, K., Van Ameringen, M., & the Canadian Anxiety Guidelines Initiative Group on behalf of the Anxiety Disorders Association of Canada/Association Canadienne des troubles anxieux and McGill University (2014) · BMC Psychiatry · doi:10.1186/1471-244x-14-s1-s1 · Cited by 1,090
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Bandelow, B., Zohar, J., Hollander, E., Kasper, S., Möller, H.-J., WFSBP TASK FORCE ON TREATMENT GUIDE, Bandelow, B., Zohar, J., Hollander, E., Kasper, S., et al. (2008) · The World Journal of Biological Psychiatry · doi:10.1080/15622970802465807 · Cited by 854
Indirect comparisons of competing interventions
Glenny, A., Altman, D., Song, F., Sakarovitch, C., Deeks, J., D'Amico, R., Bradburn, M., & Eastwood, A. (2005) · Health Technology Assessment · doi:10.3310/hta9260 · Cited by 677
Metadata
- Authors
- Piccinelli, M., Pini, S., Bellantuono, C., & Wilkinson, G.
- Venue
- British Journal of Psychiatry
- Publisher
- Royal College of Psychiatrists
- Published
- 1995-04
- Volume
- 166
- Issue
- 4
- Pages
- 424-443
- ISSN
- 0007-1250 (ISSN-L)
- 1472-1465
- OpenAlex
- W2141768440
- Cited by
- 282
- References
- 103
- FWCI
- 17.51
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.